The immunostaining markers used for distinguishing different circulating tumor cells were cytokeratins 18 (CK18), cluster of differentiation 45 (CD45), 4′,6-diamidino-2-phenylindole (DAPI) and chromosome enumeration probes 8 (CEP-8) as described in Material and Methods. This evidence concerns the gene KRT18 and neoplasm.